Our FAQs provide some additional information to help you plan and develop your Index entry. If you have a question that’s not answered in these FAQs, then please email us at:
Is there a fee to enter the Patient Partnership Index?
Who can enter the Patient Partnership Index?
Any biopharmaceutical company with partnership(s) with UK-based patient organisation(s).
Who evaluates entries to the Patient Partnership Index?
GOLD, SILVER and FINALIST standards will be awarded by a panel of expert judges using a bespoke metric developed in partnership with industry and patient organisations. Find out more about the judging panel for 2020 here.
Can I submit a project that has ended, or one that is currently underway?
Yes. You can draw on one or multiple examples of communications and advocacy partnership projects with patient organisations. These can be projects that have ended in the last 2 years or that are still in progress or on-going.
Can I make a joint submission to the Patient Partnership Index?
If more than one company have collaborated on a project, please submit the entry under the name of the lead organisation or the Secretariat.
Can I update my Patient Partnership Index entry once it’s been submitted?
You can update the patient organisation testimonial part ONLY. This update will have to be submitted via email. Please note that though we accept updated testimonials, we cannot guarantee these updates will be made.
However, in the case of genuine administrative errors, we will allow updates on a case-by-case basis.
How will you use our data and protect confidential information?
Your data will be used by OVID Health (a trading name of Ovid Consulting Ltd) and PharmaTimes Media Limited and any direct contractors/subsidiaries for the purposes of administering and promoting the Patient Partnership Index.
Award entries will be shared with the judging panel, but we will not sell or share your data with any third parties. Additionally, you may opt-in to receive other information from OVID Health and PharmaTimes, from which you can unsubscribe at any time.
By entering you allow OVID Health and PharmaTimes to use your award submission, logo(s), image(s), company information, and any other materials submitted in conjunction with the Patient Partnership Index. This may include publishing online or in print, as well as editing, re-use and dissemination on social media. We will not publish your contact details without your permission.
Entries remain the intellectual property of the company submitting them.
The Index is a good faith effort to award excellence in patient partnerships, not a data harvesting exercise. If you have any questions, please email us.
What does the Patient Partnership Index categorise as a small/medium/large organisation (as per the registration form)?
The Patient Partnership Index uses the European Commission’s guidance on SME’s to define the size of a company. This is set out in EU recommendation 2003/361 and defines company size as follows:
|Company category||Staff headcount|
|Large||250 or more|
|Medium-sized||50 to 249|
|Small||0 to 49|
The Department of Business, Energy and Industrial Strategy shares these definitions for statistical releases on business population in the UK. These ceilings apply to the figures for individual firms only. A firm that is part of a larger group should include its ‘parent’ company too.
I’m having difficulties entering the Patient Partnership Index – who do I contact?
For technical help use the email address at the top of this page.
What additional material can I supply to support my entry to the Patient Partnership Index?
The entry form asks you to answer six simple questions, share a case study of 500 words and a testimonial from a patient organisation you have worked with. No additional supporting information will be shared with the judging panel.
How will entries to the Patient Partnership Index be ranked?
Entries will not be ranked. Entries that meet the highest standard will be awarded a GOLD standard and entries that are close will receive a SILVER. Entries that are included in the Index will be awarded FINALIST standard.
Will my entry to the Patient Partnership Index be evaluated anonymously?
Judges will be able to see the name of companies and their patient organisation partners. Judges will sign a confidentiality agreement that prevents them from discussing entries outside of the judging sessions nor share any of the materials submitted. Judges who declare a conflict of interest in relation to a company’s entry will not judge those entries.
Some parts of entries may be commercially sensitive but only the judges (and PPI team) will see the entries and will not publish any sections of your entries marked ‘commercially sensitive’.
When is the deadline to enter the Patient Partnership Index?
The deadline for 2020 registration has now closed. However you can pre-register for 2021 using this registration form.
Who runs the Patient Partnership Index?
The Patient Partnership Index is a partnership between OVID Health (a trading name of Ovid Consulting Ltd) and PharmaTimes (PharmaTimes Media Limited) to celebrate and recognise best practice partnerships between biopharmaceutical companies and patient organisations. You can find out more about us via the Contact page on this website.
When will the results for the 2020 Patient Partnership Index be published?
GOLD and SILVER standards will be awarded in August 2020 and potentially feature in the September issue of PharmaTimes (we will contact all GOLD and SILVER companies on award of their Index recognition). Please note that the evolution of the COVID-19 pandemic means that these dates are under constant review. We will keep all participants updated.
Can we use the Patient Partnership Index entry and results in our marketing?
Yes. We will provide you with graphics if you are awarded GOLD, SILVER or FINALIST standard, and even just for entering!